Key result
Oral L-tyrosine supplementation improved core temperature maintenance during whole-body cooling in older adults compared to placebo (-0.07 vs -0.29 ΔTES; P<0.05).
Why the study?
Impaired reflex cutaneous vasoconstriction increases older adults' susceptibility to excess heat loss and hypothermia during cold exposure, prompting investigation into whether oral L-tyrosine attenuates core temperature decline.
Does oral L-tyrosine supplementation improve core temperature maintenance during whole-body cooling in older adults?
RCT (n=18)
double-blind
randomized
Does oral L-tyrosine supplementation improve core temperature maintenance during whole-body cooling in older adults?
Oral L-tyrosine supplementation augments the cutaneous vasoconstrictor response and improves core temperature maintenance during acute cold exposure in older adults.
Answers are grounded in this paper and cite their sources.
Supports tyrosine for core temperature preservation during cold exposure in older adults; extends thermoregulatory RCT evidence to aging populations.
INTRODUCTION: During cold exposure, an increase in sympathetic nerve activity evokes vasoconstriction (VC) of cutaneous vessels to minimize heat loss. In older adults, this reflex VC response is impaired thereby increasing their susceptibility to excess heat loss and hypothermia. Because L-tyrosine, the amino acid substrate necessary for catecholamine production, has been shown to augment reflex VC in age skin, we hypothesize that oral ingestion of L-tyrosine will attenuate the decline in core temperature (Tc) during whole-body cooling in older adults. METHODS: In a randomized, double-blind design, nine young (25 ± 3 yr) and nine older (72 ± 8 yr) participants ingested either 150 mg·kg of L-tyrosine or placebo before commencing 90 min of whole-body cooling to decrease skin temperature to approximately 29.5°C. Esophageal temperature and forearm laser Doppler flux (LDF) were measured continuously throughout the protocol to provide an index of Tc and skin blood flow, respectively. The change in esophageal temperature (ΔTES) was the difference in temperature at the end of cooling subtracted from baseline. Cutaneous vascular conductance (CVC) was calculated as CVC = LDF/mean arterial pressure and expressed as a percent change from baseline (%ΔCVCBASELINE). RESULTS: Oral tyrosine ingestion augmented the cutaneous VC response to cooling in older adults (placebo, 14.4 ± 2.0; tyrosine, 32.7% ± 1.7% ΔCVCBASELINE; P < 0.05). Additionally, tyrosine improved Tc maintenance throughout cooling in older adults (placebo, -0.29 ± 0.07; tyrosine, -0.07 ± 0.07 ΔTES; P < 0.05). Both the cutaneous VC and Tc during cooling were similar between young and older adults supplemented with tyrosine (P > 0.05). CONCLUSIONS: These results indicate that L-tyrosine supplementation improves Tc maintenance in response to acute cold exposure in an older population.
No takes yet. Share an insight, caveat, or question.
Lang et al. (2019) conducted an RCT in cold exposure (n=18). L-tyrosine vs. placebo was evaluated on change in esophageal temperature (ΔTES) during cooling in older adults (p=< 0.05). Oral L-tyrosine supplementation improved core temperature maintenance during whole-body cooling in older adults compared to placebo (-0.07 vs -0.29 ΔTES; P<0.05).
Synapse has enriched 10 related papers. Consider them for comparative context: